MoneyWorks4Me

Merck Board to consider interim dividend

10 Jan 2014 Evaluate

Merck has informed that a meeting of the Board of Directors of the Company will be held on January 31, 2014 to consider and approve the Audited Financial Results for the quarter & year ended December 31, 2013 and to consider recommendation of dividend for the year 2013.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..